Clinical trials
Chronic Kidney Disease Requiring Chronic Dialysis clinical trials
Below are recruiting chronic kidney disease requiring chronic dialysis clinical trials, each written for real people, not researchers. We’re tracking 100 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06203977RecruitingPhase 1
Can colchicine protect heart health in kidney disease?
This study tests if a low-dose anti-inflammatory medication (colchicine) can help protect the heart and blood vessels in people with advanced kidney disease or on dialysis. It aims to lower inflammation that may increase heart risks.
Edmonton, AlbertaAges 18 years+ - NCT06225544RecruitingPhase 2
Lumasiran for high oxalate patients on hemodialysis
This trial tests a drug called Lumasiran to lower oxalate levels in patients on hemodialysis (a type of kidney dialysis). It may help reduce complications from high oxalate, which can damage organs.
BerlinAges 18–80 - NCT06274710Recruiting
Kidney health support trial for those at dialysis risk
This study tests a new care program to help people with chronic kidney disease (CKD) who have a higher risk of needing dialysis soon. It uses online tools to support you and your care team in managing your health.
Toronto, OntarioAges 18 years+ - NCT06337838RecruitingPhase 3
Preventing blood loss during surgery in kidney patients
This trial tests two medications, tranexamic acid and desmopressin, to see if they can reduce bleeding during surgery in people with severe kidney disease or on dialysis. The results may help make surgery safer for you.
London, OntarioAges 18 years+ - NCT06383208Recruiting
Heart and kidney risk study for people with both diseases
This study looks at how well we can predict heart and kidney problems in people who have both coronary heart disease and chronic kidney disease. By analyzing certain markers, researchers hope to create a better risk assessment tool.
Beijing, Beijing MunicipalityAges 18–80 - NCT06463483Recruiting
Automated Insulin Delivery for People with Advanced Kidney Disease
This trial tests an automated insulin pump system for people with diabetes who also have advanced kidney disease. It may help manage blood sugar more easily.
LondonAges 18–70 - NCT06591702Recruiting
Testing a quality-of-life questionnaire for kidney disease
This study tests a questionnaire (BETY-BQ) to see how well it measures quality of life in people with kidney disease, on dialysis, or after a kidney transplant. It will help doctors better understand your symptoms and daily life.
Ankara, AltındağAges 18 years+ - NCT06635525Recruiting
How kidney failure affects your flu shot response
This study looks at how well the flu vaccine works in people with kidney failure who are on dialysis compared to healthy people. It will help doctors understand how kidney problems affect the body’s immune response to vaccination.
MilanAges 18–70 - NCT06660277Recruiting
Dialysis with expanded solute removal study
This trial tests a special dialysis filter (Elisio HX) that removes more waste products from the blood. It aims to see if this approach improves health outcomes for people on regular in-center hemodialysis.
London, OntarioAges 45 years+ - NCT06676527Recruiting
Vorolanib for advanced kidney cancer after first treatment
This trial tests a targeted therapy pill, vorolanib, for people with advanced kidney cancer that has clear cell features and has gotten worse after initial treatment. It may offer a new option when standard second-line treatments are not working.
Nanjing, JiangsuAges 18–80 - NCT06698614Recruiting
Magnetic resonance imaging to study kidney disease
This study uses a special MRI scan to look at the kidneys in people with different kinds of kidney disease, including acute kidney injury, chronic kidney disease, vasculitis, and after a kidney transplant. The goal is to better understand these conditions.
EdinburghAges 18 years+ - NCT06717698RecruitingPhase 2
Testing a new medicine for kidney damage in chronic kidney disease
This study tests different doses of an investigational medicine (NNC0519-0130) to see if it can reduce kidney damage in people with chronic kidney disease. It may be an option for you if you have kidney impairment and either have or don't have type 2 diabetes.
San Dimas, CaliforniaAges 18 years+ - NCT06721143RecruitingPhase 1/Phase 2
Study of AION-301 for chronic kidney disease
This trial tests an experimental drug called AION-301 for people with chronic kidney disease (CKD). The goal is to see if it's safe and may help slow kidney decline. It's given by IV infusion and compared to a placebo (inactive infusion).
Miami, FloridaAges 35–75 - NCT06725810RecruitingPhase 4
Enarodustat for anemia in chronic kidney disease (not on dialysis)
This trial tests enarodustat, a pill for anemia, in people with chronic kidney disease who are not on dialysis. It aims to see if it can safely raise hemoglobin levels.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06752577Recruiting
Stem cell treatment for chronic kidney disease safety study
This study tests whether a single infusion of stem cells from bone marrow is safe for people with chronic kidney disease (CKD). It aims to see if this treatment can help slow kidney function loss.
Jacksonville, FloridaAges 18 years+ - NCT06858280RecruitingPhase 3
Patiromer and diet for potassium in dialysis patients
This trial tests if a medication called patiromer, combined with a low-potassium diet, can help manage potassium levels in people on chronic dialysis. The goal is to improve quality of life by allowing a more flexible diet.
Bergamo, BGAges 18 years+ - NCT06873880Recruiting
Nutrition check for hemodialysis patients
This study looks at how well a simple body measurement combined with a blood test can help assess nutrition in people on hemodialysis. It aims to find a better way to check if you're getting enough nutrients.
Tartu, TartuAges 18 years+ - NCT06978127Recruiting
Tech help for dialysis patients to feel better
This study tests a program that uses technology to help people on dialysis feel better and take a more active role in their care. It may help you if you are on dialysis and want extra support.
Albuquerque, New MexicoAges 18 years+ - NCT07045155RecruitingPhase 4
Study of pegmolesatide for anemia in dialysis patients
This trial tests a new medication, pegmolesatide, to treat anemia in people who have been on dialysis for at least three months. It aims to help improve red blood cell levels without needing as many other anemia treatments.
Beijing, Beijing MunicipalityAges 18–80 - NCT07053462RecruitingPhase 1/Phase 2
Gene-edited kidney transplant to lower rejection risk
This trial tests a specially edited donor kidney designed to reduce the chance of rejection, especially for people with high sensitivity to donor kidneys. If it works, it could make more kidneys available for those who have a hard time finding a match.
Beijing, ChangpingAges 16–85 - NCT07064174Recruiting
Sickle cell kidney research study
This study collects kidney tissue samples from people with sickle cell disease and healthy volunteers to better understand how sickle cell affects the kidneys. If you have sickle cell disease or a related blood disorder, you may help researchers find new ways to protect kidney function.
Dallas, TexasAges 18–65 - NCT07119372RecruitingPhase 3
New drug for anemia from kidney disease on dialysis
This trial tests a new drug called BCD-131 (a biosimilar to Mircera) for treating anemia in people with kidney disease on dialysis. It compares the new drug to the standard treatment to see if it works just as well and is safe.
MinskAges 18–75 - NCT07194590RecruitingPhase 2
Equol and blood vessel health in women with kidney disease
This trial tests whether a supplement called equol, made from soy, can improve blood vessel function in postmenopausal women with moderate to advanced chronic kidney disease. Participants take equol or a placebo for several weeks to see if it helps their heart health.
Aurora, ColoradoAges 50 years+ - NCT07239570RecruitingPhase 4
Using biomarkers to personalize kidney disease treatment
This study tests if matching treatments to your specific kidney disease markers can better protect your kidneys. It looks at how well Finerenone, Dapagliflozin, and Semaglutide work alone or in a sequence.
HerlevAges 18–75
Hear when a new Chronic Kidney Disease Requiring Chronic Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for chronic kidney disease requiring chronic dialysis?
- Yes. Clin2 currently lists 100 recruiting chronic kidney disease requiring chronic dialysis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a chronic kidney disease requiring chronic dialysis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a chronic kidney disease requiring chronic dialysis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.